This agreement reinforces Lubrizol’s commitment to Make-In-India and broadens a previously committed US$ 350 million investment to support local manufacturing
Combined capabilities to drive novel healthcare applications presented at MEDICA 2024
ActivShield technology is a portable, novel sterilization modality that does not require conventional infrastructure
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
MNI is dedicated to developing and offering phytochemical (plant-based) products and healthcare solutions, aimed at treating metabolic syndrome
NMC to continue its efforts to improve and enhance the quality of medical education in the country
The collaborations will help curate industry focused courses such as Advanced Certification courses for healthcare professionals in Healthcare Marketing, Healthcare Technology and Specialized Clinical Fellowship Level programs with university accreditation
This Fast Track Designation will enable FDA to review MM-II in an expedited manner, is an important milestone in the development of MM-II
Stringent regulatory environments can make OEMs reluctant to change processes and materials for approved medical devices
Indraprastha Medical Corporation has reported total income of Rs. 352.98 crores during the quarter ended June 30, 2024
Subscribe To Our Newsletter & Stay Updated
